Paul M Arnaboldi

Title: Innovations in Lyme Disease Diagnosis by Paul M Arnaboldi

Introduction

Paul M Arnaboldi is a notable inventor based in Patterson, NY (US), recognized for his contributions to the field of medical diagnostics, particularly in relation to Lyme disease. With a total of four patents to his name, Arnaboldi has made significant strides in developing methods for diagnosing and predicting the elimination of Lyme disease spirochetes after treatment.

Latest Patents

Arnaboldi's latest patents focus on compositions and methods for diagnosing Lyme disease. These innovations include a method for confirming infection by analyzing whole blood samples from subjects suspected of having Lyme disease. The method utilizes synthetic peptides that contain T-cell epitope regions derived from proteins expressed at various stages of the disease. Additionally, the patents describe methods for predicting the elimination of Lyme disease spirochetes in patients who have undergone treatment. This is achieved by exposing whole blood samples to specific peptides and confirming the absence of activated T-cells, indicated by a lack of detectable immune response.

Career Highlights

Throughout his career, Arnaboldi has worked with prominent companies in the biotechnology sector, including Biopeptides Corporation and Qiagen Sciences, LLC. His work has been instrumental in advancing the understanding and treatment of Lyme disease, showcasing his commitment to improving patient outcomes through innovative diagnostic methods.

Collaborations

Arnaboldi has collaborated with esteemed professionals in the field, including Raymond Dattwyler and Steven M Callister. These partnerships have further enriched his research and development efforts, contributing to the success of his patented innovations.

Conclusion

Paul M Arnaboldi's work in the diagnosis and treatment of Lyme disease exemplifies the impact of innovation in medical science. His patents not only enhance diagnostic accuracy but also pave the way for improved treatment strategies for patients suffering from this condition.